These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 26372729)

  • 1. BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.
    Wang ZQ; Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Guillemette C; Gobeil S; Macdonald E; Vanderhyden B; Bachvarov D
    Oncotarget; 2015 Oct; 6(31):31522-43. PubMed ID: 26372729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
    Wang ZQ; Bachvarova M; Morin C; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Bachvarov D
    Oncotarget; 2014 Jan; 5(2):544-60. PubMed ID: 24504219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.
    Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Macdonald E; Vanderhyden B; Bachvarov D
    Oncotarget; 2016 Mar; 7(12):14125-42. PubMed ID: 26871602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells.
    Faddaoui A; Sheta R; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Ghani K; Bachvarov D
    Cell Cycle; 2017 Apr; 16(7):693-706. PubMed ID: 28278050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cells.
    Wang ZQ; Keita M; Bachvarova M; Gobeil S; Morin C; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Trinh XB; Bachvarov D
    PLoS One; 2013; 8(10):e74384. PubMed ID: 24124450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion.
    Keita M; Bachvarova M; Morin C; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Trinh XB; Bachvarov D
    Cell Cycle; 2013 Mar; 12(6):972-86. PubMed ID: 23442798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.
    Mercier PL; Bachvarova M; Plante M; Gregoire J; Renaud MC; Ghani K; Têtu B; Bairati I; Bachvarov D
    Mol Oncol; 2011 Oct; 5(5):438-53. PubMed ID: 21856257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1.
    Zhang H; Zhang X; Ji S; Hao C; Mu Y; Sun J; Hao J
    Carcinogenesis; 2014 Aug; 35(8):1863-71. PubMed ID: 24858206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
    Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
    Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
    Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
    Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
    Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
    Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer.
    Zhang L; Zhou D; Guan W; Ren W; Sun W; Shi J; Lin Q; Zhang J; Qiao T; Ye Y; Wu Y; Zhang Y; Zuo X; Connor KL; Xu G
    Cell Death Dis; 2017 Dec; 8(12):3214. PubMed ID: 29238081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3.
    Teng Y; Zhang Y; Qu K; Yang X; Fu J; Chen W; Li X
    Oncotarget; 2015 Dec; 6(38):40799-814. PubMed ID: 26512921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PFTK1 regulates cell proliferation, migration and invasion in epithelial ovarian cancer.
    Zhang W; Liu R; Tang C; Xi Q; Lu S; Chen W; Zhu L; Cheng J; Chen Y; Wang W; Zhong J; Deng Y
    Int J Biol Macromol; 2016 Apr; 85():405-16. PubMed ID: 26772918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of different GalNAc‑transferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer.
    Sheta R; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Popa I; Bachvarov D
    Int J Oncol; 2017 Dec; 51(6):1887-1897. PubMed ID: 29039611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting HSF1 leads to an antitumor effect in human epithelial ovarian cancer.
    Chen YF; Wang SY; Yang YH; Zheng J; Liu T; Wang L
    Int J Mol Med; 2017 Jun; 39(6):1564-1570. PubMed ID: 28487934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAP1 is overexpressed in human epithelial ovarian cancer and promotes cell proliferation.
    Hua M; Yan S; Deng Y; Xi Q; Liu R; Yang S; Liu J; Tang C; Wang Y; Zhong J
    Int J Mol Med; 2015 Apr; 35(4):941-9. PubMed ID: 25652936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
    Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.